Vise Technologies’s Amneal Pharmaceuticals AMRX Stock Holding History

Vise Technologies’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$128K	Hold	10,155	–	–	﹤0.01%	1413
2025 Q4	$128K	Buy	+10,155	New	+$116K	﹤0.01%	1426

Other funds holding AMRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vise Technologies's AMRX Position: Q1 2026 in Review

Vise Technologies held its Amneal Pharmaceuticals (AMRX) position steady in Q1 2026 at 10,155 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #1413.

Vise Technologies first reported a position in AMRX in Q4 2025 and has held it in 2 quarters since. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

Vise Technologies held 10,155 shares of Amneal Pharmaceuticals worth $128K as of Q1 2026.
Vise Technologies left its Amneal Pharmaceuticals share count unchanged in Q1 2026.
Amneal Pharmaceuticals made up ﹤0.01% of Vise Technologies's portfolio in Q1 2026, its #1413 holding.
Vise Technologies first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.